P-180 - MODEL-BASED POPULATION PHARMACOKINETIC ANALYSIS OF NIVOLUMAB AS ADJUVANT TREATMENT IN PATIENTS WITH ESOPHAGEAL OR GASTROESOPHAGEAL JUNCTION CANCER (CHECKMATE-577).
A. Tsujimoto1, T. Ide2, Y. Zhao2, Y. Feng2, L. Gao2; 1Bristol Myers Squibb, Shinjuku, Tokyo, 2Bristol Myers Squibb, Princeton, NJ, USA.
.png)